glp-1 neuroinflammation Anti-Inflammatory Effects of Receptor Activation in the Brain in Neurodegenerative Diseases Neuroprotective Actions of Glucagon-Like Peptide-1

BPC-157 and Digestive Balance in Research Models BPC-157 has been evaluated in extensive preclinical studies involving rodent gut injury models such as NSAID-induced damage, ulcers, and inflammation

Safety across all trials The side effect profile is consistent across studies

As these treatments become more popular, theyre changing how the industry approaches chronic diseasebringing both fresh opportunities but also new challenges

Always consult your doctor before taking a new medication

Learn More Ozempic A once-weekly injectable GLP-1 that is indicated for the treatment of Type 2 Diabetes.* Learn More Wegovy A once-weekly injectable GLP-1 indicated for the treatment of overweight and obesity